ICU Strain and Mortality Risk Among Critically Ill Patients with COVID-19

ICU Strain and Mortality Risk Among Critically Ill Patients with COVID-19

The coronavirus disease 2019 (COVID-19) pandemic has affected numerous communities, and reports of overburdened hospitals, specifically critical care units, have become commonplace. High-quality supportive care remains the... read more

De Novo Renal Failure and Clinical Outcomes of Patients With Critical COVID-19

De Novo Renal Failure and Clinical Outcomes of Patients With Critical COVID-19

This case series concludes that respiratory failure conveys significant mortality risk in patients with coronavirus disease 2019 and that survival with concomitant renal failure is rare. This is a case series of patients... read more

Harnessing a Pioneering Cell Therapy Treatment for COVID-19 Patients with ARF

Harnessing a Pioneering Cell Therapy Treatment for COVID-19 Patients with ARF

A world-leading UK-wide trial supported by NIHR is offering a pioneering cell therapy treatment for patients with acute respiratory failure (ARF) caused by COVID-19. The groundbreaking study, led by experts at Queen's... read more

Is Cardiopulmonary Resuscitation Futile in COVID-19 Patients Experiencing In-Hospital Cardiac Arrest?

Is Cardiopulmonary Resuscitation Futile in COVID-19 Patients Experiencing In-Hospital Cardiac Arrest?

COVID-19 patients suffering from in-hospital cardiac arrest had 100% in-hospital mortality regardless of the baseline comorbidities, presenting illness severity, and location of arrest. Out of 1,094 patients hospitalized... read more

COVID-19: Antibody-Dependent Enhancement

COVID-19: Antibody-Dependent Enhancement

The simple definition of ADE is “raising antibodies that don’t protect, but actually make a viral infection even worse”. And obviously, that’s the opposite of what you want. Remember that there are “neutralizing”... read more

Bacterial Superinfection Pneumonia in COVID-19 Respiratory Failure

Bacterial Superinfection Pneumonia in COVID-19 Respiratory Failure

Severe community-acquired pneumonia secondary to SARS-CoV-2 is a leading cause of death. Current guidelines recommend patients with SARS-CoV-2 pneumonia receive empirical antibiotic therapy for suspected bacterial superinfection,... read more

COVID-19 Pneumonia: Typical or Atypical Form of ARDS?

COVID-19 Pneumonia: Typical or Atypical Form of ARDS?

Evidence-based guidelines can never help a doctor resolve whether a patient is best managed by inserting an endotracheal tube or avoiding its use. That decision is based on clinical judgment, gestalt, and tacit knowledge.... read more

Deep RNA Sequencing of ICU Patients with COVID-19

Deep RNA Sequencing of ICU Patients with COVID-19

Current upper respiratory tract testing for COVID-19 only determines if the virus is present. Deep RNA sequencing with appropriate computational biology may provide important prognostic information and point to therapeutic... read more

Pre-hospital critical care management of severe hypoxemia in victims of COVID-19

Pre-hospital critical care management of severe hypoxemia in victims of COVID-19

Patients with Covid-19 and severe hypoxemia may pose a considerable challenge for the pre-hospital emergency medical services. Intubation may be associated with a high risk of complications in these patients and should be... read more

Why COVID-19 Pneumonia is More Deadly than Typical Pneumonia

Why COVID-19 Pneumonia is More Deadly than Typical Pneumonia

Bacteria or viruses like influenza that cause pneumonia can spread across large regions of the lung within hours. In the modern intensive care unit, these bacteria or viruses are usually controlled either by antibiotics or... read more

ECMO for COVID-19 patients in Europe and Israel

ECMO for COVID-19 patients in Europe and Israel

As of October 17th the novel coronavirus (SARS-CoV-2) caused a pandemic disease (coronavirus disease 2019, COVID-19) 40 million people worldwide, with almost one million deaths. Although most patients have an uncomplicated... read more

Delirium Prevalence and Risk Factors for Critically Ill COVID-19 Patients

Delirium Prevalence and Risk Factors for Critically Ill COVID-19 Patients

Acute brain dysfunction was highly prevalent and prolonged in critically ill patients with COVID-19. Benzodiazepine use and lack of family visitation were identified as modifiable risk factors for delirium, and thus these... read more

COVID-19 Blood Plasma Trial Finds No Benefit in Severely Ill Patients

COVID-19 Blood Plasma Trial Finds No Benefit in Severely Ill Patients

An international trial testing convalescent blood plasma on COVID-19 patients with moderate and severe illness has halted enrolment of severely ill COVID-19 patients requiring intensive care after it found no benefit. The... read more

Unexpectedly High Frequency of Enterococcal Bloodstream Infections in COVID-19 Patients

Unexpectedly High Frequency of Enterococcal Bloodstream Infections in COVID-19 Patients

Coronavirus disease 2019 seemed to increase the frequency of bloodstream infections (particularly Enterococcus-related bloodstream infection) after ICU admission. This may have been due to enteric involvement in patients... read more

Neutrophilic Inflammation, Immunothrombosis May Distinguish Severe COVID-19 From Influenza

Neutrophilic Inflammation, Immunothrombosis May Distinguish Severe COVID-19 From Influenza

Severe coronavirus disease 2019 (COVID-19) is associated with immunothrombotic, neutrophil-containing vessel occlusions in the lung, with neutrophils representing the primary immune cell component associated with clinical... read more

The Value of Decreasing the Duration of the Infectious Period of Severe ARDS COVID-19 Infection

The Value of Decreasing the Duration of the Infectious Period of Severe ARDS COVID-19 Infection

Finding medications or vaccines that may decrease the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could potentially reduce transmission in the broader population. We developed a computational... read more

Allergic Reactions After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

Allergic Reactions After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

Early safety monitoring of the Pfizer-BioNTech COVID-19 vaccine has detected 21 cases of anaphylaxis after reported administration of 1,893,360 first doses of Pfizer-BioNTech COVID-19 vaccine (11.1 cases per million vaccine... read more